Truist Raises Price Target on Hinge Health to $85 From $79, Keeps Buy Rating

▤ Summary

This item only shows a price target change on Hinge Health, with no operational news or company announcement in the available text. Hinge Health is a software-enabled healthcare company, so the topic remains relevant to the ISV and SaaS audience. The missing article content prevents any deeper event analysis. The piece does not indicate a new product, leadership move, acquisition, or financing round.

▦ Linked Companies